Large scale healthcare services M&A has been mostly on hold in Europe for almost three years now. Despite all the economic and geopolitical uncertainty the world is currently facing, 2025 will probably see more activity.
Elysium Healthcare, a UK-based mental health service provider which is part of Australian group Ramsay Health Care, has expanded its provision of specialist eating disorder services with the acquisition of Vivre Care, a residential care provider. Vivre Care provides specialist support for people with severe eating disorders, with its services “aligning with the NHS strategy of prioritising community-based treatment”.
Dr Oliver Harrison is the founder and chief executive of Koa Health, a UK-headquartered digital mental health company. He spoke to us about what makes Koa Health different and about the company’s new employer-funded mental health platform which he describes as the culmination of the work the company has been doing to date.
Zerenia Clinic, a UK healthcare provider specialising in medical cannabis treatment, has acquired Leva Clinic, a digital health company specialising in pain management that offers a variety of behavioural self-help tools via an app as well as cannabis medication.
Lord Ara Darzi's eagerly anticipated independent review of the National Health Service (NHS) paints a stark picture of a health system in "critical condition" but with "vital signs" that remain strong.
Minister of Health, Welfare and Sport, Fleur Agema, has found herself following the same journey as that taken by her predecessor, Conny Holder, and has abandoned plans to prohibit private equity investment in Dutch healthcare.
Cog ADHD is a digital platform for people with ADHD. The company officially launched its new app on iOS and Android earlier this month. Dom Longford, the company’s founder, explained to HBI how the platform's holistic approach to supporting people with ADHD can help fill the gaps left by failing public mental health systems.
Zerenia Clinic is a UK-based private healthcare provider specialising in treatments with cannabis-based medicinal products (CBMP). Last year it attained the UK’s first ever NHS reimbursement for cannabis flowers. In an interview with HBI, Dr. Guillermo Moreno-Sanz, Scientific Director at Zerenia’s parent company, Khiron Europe (a pharma company producing CBMPs), spoke about the growing opportunity in Europe’s medicinal cannabis space.
Access to primary care is now the number one reason people in the UK want private medical insurance (PMI), according to data collected by UK health insurer Vitality. Other NHS countries have been seeing similar trends since Covid. Katie Tryon, Vitality’s Director of Health Strategy, spoke about how this has completely changed the PMI business model — for the better — at HBI’s conference last month.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.